Key result
Chronic immunosuppression linked to ~2% higher mortality after emergent exploratory laparotomy but not other abdominal surgeries.
Why the study?
While patients on immunosuppressive agents have an increased risk for complications after surgery, the impact of these medications on outcomes in emergency general surgery remained unclear.
Does chronic immunosuppression increase mortality and complications in adult patients undergoing emergency general surgery?
Does chronic immunosuppression increase mortality and complications in adult patients undergoing emergency general surgery?
Chronic immunosuppression increases mortality risk in emergency general surgery, driven primarily by larger operations like exploratory laparotomy.
Answers are grounded in this paper and cite their sources.
Immunosuppression may heighten mortality risk after emergent laparotomy; leaves open whether targeted strategies improve outcomes.
Introduction: While patients on immunosuppressive agents are at increased risk for complications after surgery, the impact of immunosuppressive medications on surgical outcomes in the emergency setting remains unclear. As the number of people on chronic immunosuppression rises, this cohort may disproportionately contribute to outcomes associated with emergency general surgery (EGS). Study Design: We evaluated patients from a statewide EGS collaborative undergoing the following operations: cholecystectomy, appendectomy, operation for small bowel obstruction, or emergent exploratory laparotomy. The exposure was pre-existing chronic usage of corticosteroid or immunosuppressive agents. Risk-adjusted outcomes were evaluated using entropy balancing, a technique that reweights control covariates to ensure reproducible balance between the exposure and control populations without losing data. The primary outcome was mortality, and secondary outcomes included complications, readmission, and discharge disposition. We performed a sensitivity analysis with propensity score matching. Results: We identified 30,073 adult patients, of whom 1,538 (5.1%) were on chronic immunosuppression. In the overall cohort, immunosuppression medication use was associated with higher rates of mortality (marginal effect 2.3, 95% CI 1.0 – 3.6, p<0.001), complications, infection, sepsis, and readmission. Sensitivity analysis yielded similar results. On subgroup analysis by operation, only emergent exploratory laparotomy had a higher rate of mortality associated with immunosuppression use. No association between immunosuppressive mediation use and mortality was found following appendectomy, cholecystectomy, or surgery for small bowel obstruction. Conclusions: Patients on chronic immunosuppression medication constitute a substantial portion of the EGS population. Mortality rates are worse for larger operations such as exploratory laparotomy in this population. Less complicated operations such as cholecystectomy and appendectomy can be performed safely without increased risk of mortality in this population, despite a modest increase in non-fatal complications.
No takes yet. Share an insight, caveat, or question.
Levy et al. (2026) studied this question. Chronic immunosuppression increases mortality by 2.3% after emergent exploratory laparotomy but not after appendectomy, cholecystectomy, or small bowel obstruction surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: